These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15935208

  • 1. Effects of homocysteine on the dopaminergic system and behavior in rodents.
    Lee ES, Chen H, Soliman KF, Charlton CG.
    Neurotoxicology; 2005 Jun; 26(3):361-71. PubMed ID: 15935208
    [Abstract] [Full Text] [Related]

  • 2. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR, Lee ES, Schmued L, Jiao Y, Ali SF, Oriaku ET, Lamango NS, Soliman KF, Charlton CG.
    Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
    [Abstract] [Full Text] [Related]

  • 3. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats.
    Lee ES, Soliman KF, Charlton CG.
    Neurotoxicology; 2005 Jan; 26(1):27-38. PubMed ID: 15527871
    [Abstract] [Full Text] [Related]

  • 4. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 5. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
    Li X, Yin J, Cheng CM, Sun JL, Li Z, Wu YL.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1357-61. PubMed ID: 16157030
    [Abstract] [Full Text] [Related]

  • 6. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 20; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 May 05; 151(1-2):191-9. PubMed ID: 15084435
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Agrawal AK.
    Neurosci Lett; 2006 May 01; 398(1-2):44-9. PubMed ID: 16423459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of pyrethroids on tyrosine hydroxylase in nigrostriatum of male rats].
    Liu G, Shi N, Ma R.
    Wei Sheng Yan Jiu; 2004 Jul 01; 33(4):390-3. PubMed ID: 15461254
    [Abstract] [Full Text] [Related]

  • 17. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
    Themann C, Alvarez Fischer D, Gross S, Westermann R, Weihe E, Kuschinsky K, Schäfer H, Ferger B.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan 01; 365(1):22-8. PubMed ID: 11862330
    [Abstract] [Full Text] [Related]

  • 18. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F, Chalansonnet M, Carabin N, Micillino JC.
    Arch Toxicol; 2006 Oct 01; 80(10):703-12. PubMed ID: 16518643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.